CVE-2023-40279 Path traversal in n/a

What is CVE-2023-40279?

CVE-2023-40279 is a high-severity path traversal vulnerability in n/a, published on 19 Mar 2024. An attacker can exploit it over the internet without logging in, with no action from the victim.

Official description

An issue was discovered in OpenClinic GA 5.247.01. An attacker can perform a directory path traversal via the Page parameter in a GET request to main.do.

Weakness: CWE-22

Which versions are affected by CVE-2023-40279?

It affects 1 product.

Products include Openclinic Ga Project Openclinic Ga.

How do I fix CVE-2023-40279?

No fix has been published for CVE-2023-40279 yet. Limit exposure of the affected software until one is available.

Upgrade, and resolve every user-supplied path against an allowed base folder before opening it. More about Path traversal.

Is CVE-2023-40279 being exploited?

It is not confirmed as exploited in the wild, but public exploit code for CVE-2023-40279 exists.

Public exploit code: 1 Exploit-DB entry.

Other vulnerabilities in n/a

• CVE-2020-27227 Command injection in OpenClinic Critical 10.0
• CVE-2020-14484 Security feature bypass in OpenClinic GA Critical 9.8
• CVE-2020-14485 Auth bypass in OpenClinic GA Critical 9.8
• CVE-2020-14494 Auth bypass in OpenClinic GA Critical 9.8
• CVE-2023-40275 Information disclosure in n/a Critical 9.1

Sources

• CVE record
• NVD
• OSV
• GitHub advisory
• How this page is made

Also known as GHSA-964h-h45x-xm3j.